Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 15,048 | 23,017 | 13,782 | 14,245 | 16,627 |
| Gross Profit | 15,048 | 23,017 | 13,782 | 14,245 | 16,627 |
| Operating Expenses | 115,580 | 121,727 | 125,259 | 124,241 | 137,434 |
| Operating Income | -100,532 | -98,710 | -111,477 | -109,996 | -120,807 |
| Other Income | 4,301 | 2,924 | 10,153 | 8,741 | 6,478 |
| Pre-tax Income | -96,231 | -95,786 | -101,324 | -101,255 | -114,329 |
| Net Income Continuous | -96,231 | -95,786 | -101,324 | -101,255 | -114,329 |
| Net Income | $-96,231 | $-95,786 | $-101,324 | $-101,255 | $-114,329 |
| EPS Basic Total Ops | -0.81 | -0.81 | -0.92 | -0.98 | -1.10 |
| EPS Basic Continuous Ops | -0.81 | -0.81 | -0.92 | -0.98 | -1.10 |
| EPS Diluted Total Ops | -0.81 | -0.81 | -0.92 | -0.98 | -1.10 |
| EPS Diluted Continuous Ops | -0.81 | -0.81 | -0.92 | -0.98 | -1.10 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.83 | -0.92 | -0.99 | -1.10 |
| EBITDA(a) | $-98,330 | $-92,695 | $-106,541 | $-107,522 | $-118,309 |